Sean J Pittock

The spectrum of neuromyelitis optica

B. Weinshenker, C. Lucchinetti, D. Wingerchuk, 2007, The Lancet Neurology.

Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population

Moses Rodriguez, Robyn L McClelland, J. Matsumoto, 2004, Movement disorders : official journal of the Movement Disorder Society.

Neuromyelitis optica and non organ-specific autoimmunity.

Patrick Vermersch, P. Vermersch, B. Weinshenker, 2008, Archives of neurology.

Amphiphysin autoimmunity: Paraneoplastic accompaniments

Joseph E Parisi, J. Parisi, B. Mokri, 2005, Annals of neurology.

The Pathology of MS: New Insights and Potential Clinical Applications

C. Lucchinetti, S. Pittock, Claudia F Lucchinetti, 2007, The neurologist.

Clinical implications of benign multiple sclerosis: A 20‐year population‐based follow‐up study

John Noseworthy, Moses Rodriguez, Robyn L McClelland, 2004, Annals of neurology.

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Ichiro Nakashima, K. Fujihara, B. Weinshenker, 2004, The Lancet.

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Gary R Cutter, Friedemann Paul, Fred D Lublin, 2019, The Lancet.